Publications by authors named "Pawel Rogala"

Claim this Profile
E
Efficacy of radiotherapy and radiotherapy with hyperthermia to delay change of systemic therapy in patients with metastatic melanoma.
Paulina Chmiel, Mateusz Jacek Spałek, Hanna Koseła-Paterczyk, Piotr Łukasz Rutkowski, Paulina Jagodzińska-Mucha, Paweł Rogala

Clin Transl Radiat Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes of sequential chemotherapy in epithelioid sarcoma.
Anna M Czarnecka, Paulina Chmiel, Piotr Błoński, Tomasz Świtaj, Paweł Rogala

J Chemother· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life data on tebentafusp in metastatic uveal melanoma patients from four EURACAN Expert Centres.
Monique K van der Kooij, Ellen Kapiteijn, Piotr Rutkowski, Jean-François Baurain, Leanne de Koning, Paweł Rogala

Eur J Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes of metastatic clear cell sarcoma sequential chemotherapy.
Anna M Czarnecka, Paulina Chmiel, Piotr J Błoński, Tomasz Świtaj, Paweł Rogala

J Chemother· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avelumab plus axitinib in patients with advanced gastrointestinal stromal tumor.
Piotr Lukasz Rutkowski, Anna Klimczak, Pawel Teterycz, Maria Abbondanza Pantaleo, Tomasz Switaj, Pawel Rogala

Eur J Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic inflammation index is a predictive and prognostic factor in patients with liposarcoma or leiomyosarcoma treated with trabectedin.
Pawel Sobczuk, Paulina Filipowicz, Lukasz Lamparski, Hanna Kosela-Paterczyk, Pawel Teterycz, Paweł Rogala

Sci Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy of neoadjuvant-adjuvant targeted therapy in borderline resectable stage IIIB-D and IV melanoma.
Anna M Czarnecka, Krzysztof Ostaszewski, Piotr J Błoński, Anna Szumera-Ciećkiewicz, Tomasz Świtaj, Paweł Rogala

Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative-postoperative immunotherapy as treatment of borderline resectable and oligoprogressive stage III B-D and IV melanoma.
Anna M Czarnecka, Krzysztof Ostaszewski, Piotr Błoński, Anna Szumera-Ciećkiewicz, Katarzyna Kozak, Paweł Rogala

Eur J Surg Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or Targeted Therapy: Multicenter Real-World Report.
Joanna Placzke, Magdalena Rosińska, Paweł Sobczuk, Marcin Ziętek, Natasza Kempa-Kamińska, Paweł Rogala

Cancers (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What impact will BRAF/MEK-inhibitors have on the melanoma treatment armamentarium and are there challenges ahead?
Piotr Rutkowski, Paweł Rogala

Expert Opin Pharmacother· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myocarditis Induced by Immunotherapy in Metastatic Melanoma-Review of Literature and Current Guidelines.
Anna M Czarnecka, Marcin Kleibert, Iga Płachta, Paweł Rogala, Michał Wągrodzki

J Clin Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of immunotherapy beyond RECIST progression in advanced melanoma: a real-world evidence.
Anna Małgorzata Czarnecka, Paweł Sobczuk, Paweł Rogala, Tomasz Świtaj, Joanna Placzke

Cancer Immunol Immunother· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Giant cell tumor of the sella as a rare cause of hyperprolactinemia.
Jacek Kunicki, Natalia Rzewuska, Michał Kunicki, Paweł Rogala, Michał Wągrodzki

Pol Arch Intern Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Outcomes of Targeted Therapy after First-Line Immunotherapy in BRAF-Mutated Advanced Cutaneous Melanoma Patients-Real-World Evidence.
Paweł Rogala, Anna M Czarnecka, Bożena Cybulska-Stopa, Krzysztof Ostaszewski, Karolina Piejko

J Clin Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma Patients.
Paweł Rogala, Anna M Czarnecka, Bożena Cybulska-Stopa, Krzysztof Ostaszewski, Karolina Piejko

Cancers (Basel)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Use of ctDNA for Mutation Testing in Routine Clinical Practice in Patients with Advanced Melanoma.
Paweł Sobczuk, Katarzyna Kozak, Sylwia Kopeć, Paweł Rogala, Tomasz Świtaj

Cancers (Basel)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Locally Advanced Merkel Cell Carcinoma-A Multi-Center Study.
Monika Dudzisz-Sledz, Paweł Sobczuk, Katarzyna Kozak, Tomasz Switaj, Hanna Kosela-Paterczyk, Paweł Rogala

Cancers (Basel)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Neoadjuvant Targeted Therapy for Borderline Resectable III B-D or IV Stage BRAF Mutation-Positive Melanoma.
Anna M Czarnecka, Krzysztof Ostaszewski, Aneta Borkowska, Anna Szumera-Ciećkiewicz, Katarzyna Kozak, Paweł Rogala

Cancers (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensors to Detect Sarin Simulant.
Marcin Bielecki, Zygfryd Witkiewicz, Paweł Rogala

Crit Rev Anal Chem· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line treatment of advanced/metastatic melanoma with anti-PD-1 antibodies: multicenter experience in Poland.
Bożena Cybulska-Stopa, Renata Pacholczak-Madej, Grażyna Kamińska-Winciorek, Marcin Ziętek, Anna M Czarnecka, Paweł Rogala

Immunotherapy· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A durable complete response to immunotherapy in a patient with metastatic alveolar soft part sarcoma.
Anna Mariuk-Jarema, Hanna Koseła-Paterczyk, Paweł Rogala, Anna Klimczak, Michał Wągrodzki

Tumori· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body mass index (BMI) and outcome of metastatic melanoma patients receiving targeted therapy and immunotherapy: a multicenter international retrospective study.
Piotr Rutkowski, Alice Indini, Matilde De Luca, Barbara Merelli, Anna Mariuk-Jarema, Pawel Rogala

J Immunother Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF and MEK inhibitors rechallenge as effective treatment for patients with metastatic melanoma.
Bożena Cybulska-Stopa, Paweł Rogala, Anna M Czarnecka, Łukasz Galus, Robert Dziura

Melanoma Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodal Treatment of Advanced Mucosal Melanoma in the Era of Modern Immunotherapy.
Pawel Teterycz, Anna M Czarnecka, Alice Indini, Mateusz J Spałek, Alice Labianca, Pawel Rogala

Cancers (Basel)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of ipilimumab after anti-PD-1 therapy in sequential treatment of metastatic melanoma patients - Real world evidence.
Bożena Cybulska-Stopa, Paweł Rogala, Anna M Czarnecka, Iwona Ługowska, Paweł Teterycz

Adv Med Sci· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis